US Stock MarketDetailed Quotes
DXCM DexCom
- 124.340
- -13.670-9.91%
Close Apr 26 16:00 ET
- 124.380
- +0.040+0.03%
Post 19:54 ET
49.45BMarket Cap80.74P/E (TTM)
138.805High124.080Low8.58MVolume132.500Open138.010Pre Close1.10BTurnover2.20%Turnover Ratio95.65P/E (Static)397.68MShares142.00052wk High22.01P/B48.52BFloat Cap74.75052wk Low--Dividend TTM390.22MShs Float164.863Historical High--Div YieldTTM10.67%Amplitude0.340Historical Low127.944Avg Price1Lot Size
About DexCom Company
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.
Company Profile
SymbolDXCM
Company NameDexCom
Listing DateApr 14, 2005
Issue Price12.00
Founded1999
MarketNASDAQ
Employees9600
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address6340 Sequence Drive
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-200-0200
Websitehttp://www.dexcom.com
Company Executives
- Name
- Position
- Salary
- Kevin R. Sayer, C.P.A.
- President, Chief Executive Officer and Chairman of the Board
- 15.71M
- Michael Brown
- Executive Vice President and Chief Legal Officer
- 4.34M
- Jereme M. Sylvain
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- 4.25M
- Sadie Stern
- Executive Vice President and Chief Human Resources Officer
- --
- Teri L Lawver
- Executive Vice President and Chief Commercial Officer
- 6.53M
- Jake Leach
- Executive Vice President and Chief Operating Officer
- 4.94M
- Matthew Vincent Dolan
- Executive Vice President, Strategy, Corporate Development and Dexcom Labs
- --
- Kyle Malady
- Independent Director
- 343.40K
- Nicholas Augustinos
- Independent Director
- 362.21K
- Steven R. Altman
- Independent Director
- 343.40K
- Dr. Barbara E. Kahn
- Independent Director
- 348.40K
- Bridgette P. Heller
- Independent Director
- 346.49K
- Karen M. Dahut
- Independent Director
- 345.90K
- Mark G. Foletta
- Lead Independent Director
- 393.51K
- Richard A. Collins
- Independent Director
- 345.90K
- Rimma Driscoll
- Independent Director
- 404.72K
- Professor Dr. Eric J. Topol, M.D.
- Independent Director
- 346.49K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
